v3.25.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2023
Cash flows from operating activities:      
Net income $ 73,133 $ 68,438 $ 70,197
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization of property and equipment 6,232 6,426 6,345
Amortization of acquired intangibles and other 145,492 96,618 96,802
Amortization of debt discount and issuance costs 5,831 3,525 2,147
Stock-based compensation 64,768 46,756 40,529
Non-cash lease expense 11,181 11,723 9,393
Deferred income taxes (23,429) (7,750) (28,641)
Credit losses and other sales allowances 4,519 544 488
Changes in operating assets and liabilities:      
Accounts receivable (46,570) (45,880) 12,119
Other assets (9,875) (2,897) (1,579)
Inventories 0 0 2,489
Accounts payable and accrued liabilities (798) 28,922 (1,242)
Lease liabilities (12,006) (11,556) (10,472)
Income taxes payable 3,165 442 (553)
Deferred revenue 13,544 16,183 (24,102)
Net cash flows from operating activities 235,187 211,494 173,920
Cash flows used in investing activities:      
Purchases of investments 0 0 (15,262)
Sales and maturities of investments 0 0 15,700
Purchases of property and equipment (5,702) (5,206) (5,570)
Payments for acquisitions, net of cash acquired (21,217) (852,702) (355,250)
Net cash flows used in investing activities (26,919) (857,908) (360,382)
Cash flows (used in) from financing activities:      
Proceeds from equity plans 18,968 27,761 25,956
Payments for taxes related to net share settlements of equity awards (15,184) (17,170) (12,377)
Repurchases of common stock (105,156) (86,777) (33,962)
Proceeds from issuance of convertible senior notes, net of issuance costs of $11,200 0 438,750 0
Purchase of capped calls 0 (42,210) 0
Dividend equivalent and dividend payments to stockholders (786) (31,460) (31,554)
Proceeds from the issuance of debt 0 730,000 195,000
Repayment of revolving line of credit (130,000) (110,000) (85,000)
Principal payment on term loan 0 (261,250) (6,875)
Payment of credit facility debt issuance costs (6,211) (6,821) 0
Net cash flows (used in) from financing activities (238,369) 640,823 51,188
Effect of exchange rate changes on cash 6,831 (3,290) 5,955
Net decrease in cash and cash equivalents (23,270) (8,881) (129,319)
Cash and cash equivalents, beginning of year 118,077 126,958 256,277
Cash and cash equivalents, end of year 94,807 118,077 126,958
Supplemental disclosure:      
Cash paid for income taxes, net of refunds of $2,509, $2,881, and $965 in 2025, 2024 and 2023, respectively 34,353 32,386 39,771
Cash paid for interest 63,524 21,771 23,867
Non-cash investing and financing activities:      
Dividends declared and unpaid 0 0 8,376
Contingent consideration payable in Nuclia acquisition $ 1,080 $ 0 $ 0